This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Leids Universitair Medisch Centrum, Natuurwetenschappelijk Onderzoek Tno Leids Universitair Medisch Centrum. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Voorhout, NL (2008 - 2010)
- NP Voorhout, NL (2011)
Company Filing History:
4 out of 1,211 
1 out of 2 
1 out of 1 Years Active: 2008-2011
Title: Jan Roeland Occo Hanemaaijer: Innovator in Diabetes and Complement System Research
Introduction
Jan Roeland Occo Hanemaaijer is a notable inventor based in Voorhout, Netherlands. He has made significant contributions to the fields of diabetes research and the complement system. With a total of 4 patents, his work focuses on innovative methods that enhance the understanding and treatment of medical conditions.
Latest Patents
One of Hanemaaijer's latest patents is a method for determining if a subject with type II diabetes has a kidney disorder. This invention involves measuring the level of matrix metalloproteinase 8 (MMP-8) in the urine of the subject and comparing it to reference samples. The presence of increased levels of MMP-8 indicates a potential kidney disorder. Another significant patent is related to the functional determination of mannan-binding-lectin associated serine proteases (MASPs). This method allows for the detection and quantification of the activity of MASPs and their complexes, which are crucial components of the complement system.
Career Highlights
Throughout his career, Hanemaaijer has worked with esteemed organizations such as the Netherlands Organization for Applied Scientific Research (TNO). His research has contributed to advancements in medical diagnostics and therapeutic approaches.
Collaborations
Hanemaaijer has collaborated with notable colleagues, including Johan Hendrikus Verheijen and Michaela Diamant. These partnerships have fostered a collaborative environment that enhances the impact of their research.
Conclusion
Jan Roeland Occo Hanemaaijer is a distinguished inventor whose work in diabetes and complement system research has led to valuable innovations. His contributions continue to influence the medical field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile